Global Market Access via Strategic Reimbursement
Securing coverage approval and profitable payment rates is the single greatest hurdle for new drugs and medical devices today.
Mediclever eliminates the complexity of global healthcare systems. We move your product from "regulatory cleared" to "revenue generating" by navigating the intricate landscape of payer policies, coding submissions, and health economics.
Coding
Identifying and securing the right HCPCS, CPT, or country-specific codes (e.g., TARDOC in Switzerland) to ensure your product is recognizable by payers.
Coverage
Developing clinical evidence strategies and dossiers to satisfy payer requirements and secure positive medical policy determinations.
Payment
Negotiating payment rates and hospital add-on funding (NUB in Germany or LPPR in France) to ensure commercial viability and ROI.
Why choose Mediclever as your reimbursement partner:
-
Two Decades of Global Expertise:
Helping startups and Fortune 500 companies alike navigate the "Valley of Death" between regulatory approval and actual payment across the U.S. and Europe.
-
Payer-Centric Team:
Our network includes former payer medical directors, public policy specialists, and health economists who understand exactly how coverage decisions are made.
-
Proven Track Record:
We've guided hundreds of life science clients through successful code applications, coverage expansions, and market access launches.
-
Flat Fees & Concrete Timelines:
No hidden costs. You will know exactly what the reimbursement process entails, how long it will take, and the total investment required.
-
Global Coverage:
We provide localized expertise for medical device and drug reimbursement in the following markets: